EC
FLGT icon

EntryPoint Capital’s Fulgent Genetics FLGT Stock Holding History

EntryPoint Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Buy
15,745
+8,106
+106% +$176K 0.07% 545
2025
Q4 		$201K Sell
7,639
-1,693
-18% -$43.9K 0.08% 555
2025
Q3 		$211K Buy
+9,332
New +$192K 0.08% 533
2025
Q1 		– Sell
-20,771
Closed -$384K – 761
2024
Q4 		$384K Buy
20,771
+9,556
+85% +$187K 0.16% 223
2024
Q3 		$244K Buy
+11,215
New +$251K 0.14% 352
2024
Q2 		– Sell
-15,622
Closed -$339K – 1131
2024
Q1 		$339K Buy
15,622
+15,519
+15,067% +$385K 0.3% 12
2023
Q4 		$2.98K Buy
+103
New +$2.76K ﹤0.01% 1255

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return